abrdn Life Sciences Investors

HQL

Exchange: NYSE
SEC CIK: 0000884121

SEC filings (opens in a new tab)

In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.

Superinvestors holding HQL, Q2 2026

See all superinvestors

No superinvestor reported holding HQL in Q2 2026.